Lenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study von Williams, Michael E., Goy, Andre, Sinha, Rajni, Kalayoglu Besisik, Sevgi, Drach, Johannes W., Ramchandren, Rod, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Witzig, Thomas E

Volltext

Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma von Witzig, Thomas E., Vose, Julie, Zinzani, Pier Luigi, Habermann, Thomas Matthew, Tuscano, Joseph M., Sinha, Rajni, Williams, Michael E., Drach, Johannes W., Ramchandren, Rod, Kalayoglu Besisik, Sevgi, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Goy, Andre

Volltext

Fluorescent In Situ Hybridization and Cytogenetic Studies of Trisomy 12 in Chronic Lymphocytic Leukemia von Escudier, Susan M., Pereira-Leahy, Josefina M., Drach, Johannes W., Weier, H.U., Goodacre, Angela M., Cork, M. Ann, Trujillo, Jose M., Keating, Michael J., Andreeff, Michael

Volltext

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response von JÄGER, Ulrich, FRIDRIK, Michael, EINBERGER, Christine, DRACH, Johannes, RADERER, Markus, GAIGER, Alexander, PUTMAN, Monique, GREIL, Richard, ZEITLINGER, Markus, HEINTEL, Daniel, HOPFINGER, Georg, BURGSTALLER, Sonja, MANNHALTER, Christine, OBERAIGNER, Wilhelm, PORPACZY, Edit, SKRABS, Cathrin

Volltext

IMWG consensus on risk stratification in multiple myeloma von Chng, W J, Dispenzieri, A, Chim, C-S, Fonseca, R, Goldschmidt, H, Lentzsch, S, Munshi, N, Palumbo, A, Miguel, J S, Sonneveld, P, Cavo, M, Usmani, S, Durie, B GM, Avet-Loiseau, H

Volltext

Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma von LAMM, Wolfgang, KAUFMANN, Hannes, RADERER, Markus, HOFFMANN, Martha, CHOTT, Andreas, ZIELINSKI, Christoph, DRACH, Johannes

Volltext

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines fo... von Kyle, R A, Durie, B G M, Rajkumar, S V, Landgren, O, Blade, J, Merlini, G, Kröger, N, Einsele, H, Vesole, D H, Dimopoulos, M, San Miguel, J, Avet-Loiseau, H, Hajek, R, Chen, W M, Anderson, K C, Ludwig, H, Sonneveld, P, Pavlovsky, S, Palumbo, A, Richardson, P G, Barlogie, B, Greipp, P, Vescio, R, Turesson, I, Westin, J, Boccadoro, M

Volltext

A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma von Petrucci, Maria T., Giraldo, Pilar, Corradini, Paolo, Teixeira, Adriana, Dimopoulos, Meletios A., Blau, Igor W., Drach, Johannes, Angermund, Ralf, Allietta, Nathalie, Broer, Esther, Mitchell, Vivien, Bladé, Joan

Volltext

Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma von Atamaniuk, Johanna, Gleiss, Andreas, Porpaczy, Edit, Kainz, Birgit, Grunt, Thomas W., Raderer, Markus, Hilgarth, Bernadette, Drach, Johannes, Ludwig, Heinz, Gisslinger, Heinz, Jaeger, Ulrich, Gaiger, Alexander

Volltext

Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience von Posch, Doris, Rabitsch, Werner, Wohlfarth, Philipp, Leiner, Michael, Porpaczy, Edit, Drach, Johannes, Raderer, Markus, Lamm, Wolfgang

Volltext

Genetics and cytogenetics of multiple myeloma: a workshop report von Fonseca, Rafael, Barlogie, Bart, Bataille, Regis, Bastard, Christian, Bergsagel, P Leif, Chesi, Marta, Davies, Faith E, Drach, Johannes, Greipp, Philip R, Kirsch, Ilan R, Kuehl, W Michael, Hernandez, Jesus M, Minvielle, Stephane, Pilarski, Linda M, Shaughnessy, Jr, John D, Stewart, A Keith, Avet-Loiseau, Herve

Volltext

Myelomastocytic Leukemia: Evidence for the Origin of Mast Cells from the Leukemic Clone and Eradication by Allogeneic Stem Cell Transplantation von Sperr, Wolfgang R, Drach, Johannes, Hauswirth, Alexander W, Ackermann, Jutta, Mitterbauer, Margit, Mitterbauer, Gerlinde, Foedinger, Manuela, Fonatsch, Christa, Simonitsch-Klupp, Ingrid, Kalhs, Peter, Valent, Peter

Volltext

Effects of single‐agent bortezomib as post‐transplant consolidation therapy on multiple myeloma‐related bone disease: a randomized phase II study von Sezer, Orhan, Beksac, Meral, Hajek, Roman, Sucak, Gülsan, Cagirgan, Seckin, Linkesch, Werner, Meltem Akay, Olga, Gülbas, Zafer, Nahi, Hareth, Plesner, Torben, Snowden, John A., Timurağaoğlu, Ayşen, Dechow, Tobias, Lang, Alois, Tuğlular, Tülin, Drach, Johannes, Armbrecht, Gabriele, Potamianou, Anna, Couturier, Catherine, Olie, Robert A., Feys, Caroline, Allietta, Nathalie, Terpos, Evangelos

Volltext

Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma von Raderer, Markus, Jäger, Gerald, Brugger, Stefan, Püspök, Andreas, Fiebiger, Wolfgang, Drach, Johannes, Wotherspoon, Andrew, Chott, Andreas

Volltext

DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies von Takahashi, Takao, Shivapurkar, Narayan, Reddy, Jyotsna, Shigematsu, Hisayuki, Miyajima, Kuniharu, Suzuki, Makoto, Toyooka, Shinichi, Zöchbauer-Müller, Sabine, Drach, Johannes, Parikh, Gunjan, Zheng, Yingye, Feng, Ziding, Kroft, Steven H, Timmons, Charles, McKenna, Robert W, Gazdar, Adi F

Volltext

Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics von Oehler, L, Majdic, O, Pickl, W F, Stöckl, J, Riedl, E, Drach, J, Rappersberger, K, Geissler, K, Knapp, W

Volltext

Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors von Reddy, Jyotsna, Shivapurkar, Narayan, Takahashi, Takao, Parikh, Gunjan, Stastny, Victor, Echebiri, Chinyere, Crumrine, Katherine, Zöchbauer-Müller, Sabine, Drach, Johannes, Zheng, Yingye, Feng, Ziding, Kroft, Steven H, McKenna, Robert W, Gazdar, Adi F

Volltext

Retraction: DNA methylation profiles of lymphoid and hematopoietic malignancies von Takahashi, Takao, Shivapurkar, Narayan, Reddy, Jyotsna, Shigematsu, Hisayuki, Miyajima, Kuniharu, Suzuki, Makoto, Toyooka, Shinichi, Zöchbauer-Müller, Sabine, Drach, Johannes, Parikh, Gunjan, Zheng, Yingye, Feng, Ziding, Kroft, Steven H, Timmons, Charles, McKenna, Robert W, Gazdar, Adi F

Volltext

Efficacy and Safety of Retreatment with Bortezomib in Patients with Multiple Myeloma: Interim Results From RETRIEVE, a Prospective International Phase 2 Study von Teresa Petrucci, Maria, Blau, Igor W., Corradini, Paolo, Dimopoulos, Meletios A., Drach, Johannes, Giraldo, Pilar, Teixeira, Adriana, Blade, Joan

Volltext

Open-label, Randomized Study of Pegfilgrastim vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma von Grigg, Andrew, Solal-Celigny, Philippe, Hoskin, Peter, Taylor, Kerry, M, Andrew

Volltext